IRadimed

About IRadimed

IRadimed Corporation is a specialized medical device company that develops, manufactures, and markets equipment designed specifically for the magnetic resonance imaging (MRI) environment. The company's core focus is on addressing the engineering challenge of creating infusion pumps and patient monitoring systems that can operate safely and effectively within the strong magnetic fields of MRI suites. Its products are sold to hospitals, acute care facilities, and outpatient imaging centers globally.

The company was founded in 1992 by Roger Susi, a biomedical engineer, who pioneered MRI-safe patient monitoring. Susi had previously founded Invivo Research Inc., which developed the first MRI patient vital signs monitor. His experience and engineering background were instrumental in establishing IRadimed, which was officially incorporated in 2004. A significant milestone was the 2005 launch of the MRidium, the world's first non-magnetic IV infusion pump. The company later went public in 2014.

IRadimed's product portfolio is centered around providing a continuum of care for patients, particularly high-acuity and pediatric patients, who need to be moved from their care unit to the MRI suite. Key products include the 3880 MRI Patient Monitor System, a portable, non-magnetic monitor for vital signs, and the MRidium series of MRI IV Infusion Pump Systems, which allow for the continuous delivery of medications during scans. These systems are designed with non-ferrous components to ensure they do not interfere with the MRI scanner or pose a safety risk. The company also produces ferrous metal detection systems to enhance safety in the MRI suite. IRadimed's business model involves the sale of these capital equipment devices, as well as related disposables, accessories, and service contracts.